Step-up therapy in uncontrolled asthma: Choices and outcomes

被引：4

作者：

Sears, Malcolm R. ^{[1
]}

机构：

[1] McMaster Univ, Firestone Inst Resp Hlth, St Josephs Healthcare Hamilton, Hamilton, ON L8N 4A6, Canada

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2009年 / 123卷 / 01期

关键词：

Asthma; inhaled corticosteroids; long-acting beta-agonist; RANDOMIZED CONTROLLED TRIAL; BRONCHODILATOR TREATMENT; PERSISTENT ASTHMA; SALMETEROL; BETA(2)-AGONIST; EXACERBATIONS; GUIDE;

D O I：

10.1016/j.jaci.2008.10.045

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：122 / 123

页数：2

共 15 条

[1] Global strategy for asthma management and prevention: GINA executive summary [J].

Bateman, E. D. ;

Hurd, S. S. ;

Barnes, P. J. ;

Bousquet, J. ;

Drazen, J. M. ;

FitzGerald, M. ;

Gibson, P. ;

Ohta, K. ;

O'Byrne, P. ;

Pedersen, S. E. ;

Pizzichini, E. ;

Sullivan, S. D. ;

Wenzel, S. E. ;

Zar, H. J. .

EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) :143-178

[2] Indacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthma [J].

Beeh, K. M. ;

Derom, E. ;

Kanniess, F. ;

Cameron, R. ;

Higgins, M. ;

van As, A. .

EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (05) :871-878

[3] Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma [J].

Buhl, R. ;

Vogelmeier, C. .

CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (08) :1867-1878

[4] SEREVENT NATIONWIDE SURVEILLANCE STUDY - COMPARISON OF SALMETEROL WITH SALBUTAMOL IN ASTHMATIC-PATIENTS WHO REQUIRE REGULAR BRONCHODILATOR TREATMENT [J].

CASTLE, W ;

FULLER, R ;

HALL, J ;

PALMER, J .

BRITISH MEDICAL JOURNAL, 1993, 306 (6884) :1034-1037

[5] ADDED SALMETEROL VERSUS HIGHER-DOSE CORTICOSTEROID IN ASTHMA PATIENTS WITH SYMPTOMS ON EXISTING INHALED CORTICOSTEROID [J].

GREENING, AP ;

IND, PW ;

NORTHFIELD, M ;

SHAW, G .

LANCET, 1994, 344 (8917) :219-224

[6] Determining asthma treatment by monitoring sputum cell counts:: effect on exacerbations [J].

Jayaram, L ;

Pizzichini, MM ;

Cook, RJ ;

Boulet, LP ;

Lemière, C ;

Pizzichini, E ;

Cartier, A ;

Hussack, P ;

Goldsmith, CH ;

Laviolette, M ;

Parameswaran, K ;

Hargreave, FE .

EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) :483-494

[7] Long-acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma -: A randomized controlled trial [J].

Lazarus, SC ;

Boushey, HA ;

Fahy, JV ;

Chinchilli, VM ;

Lemanske, RF ;

Sorkness, CA ;

Kraft, M ;

Fish, JE ;

Peters, SP ;

Craig, T ;

Drazen, JM ;

Ford, JG ;

Israel, E ;

Martin, RJ ;

Mauger, EA ;

Nachman, SA ;

Spahn, JD ;

Szefler, SJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (20) :2583-2593

[8] Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial [J].

Lemanske, RF ;

Sorkness, CA ;

Mauger, EA ;

Lazarus, SC ;

Boushey, HA ;

Fahy, JV ;

Drazen, JM ;

Chinchilli, VM ;

Craig, T ;

Fish, JE ;

Ford, JG ;

Israel, E ;

Kraft, M ;

Martin, RJ ;

Nachman, SA ;

Peters, SP ;

Spahn, JD ;

Szefler, SJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (20) :2594-2603

[9]

McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924

[10] The salmeterol multicenter asthma research trial - A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol [J].

Nelson, HS ;

Weiss, ST ;

Bleecker, ER ;

Yancey, SW ;

Dorinsky, PM .

CHEST, 2006, 129 (01) :15-26

← 1 2 →